[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D004176:Dipyridamole / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005480:Flurbiprofen / Q000627:therapeutic use; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects; D011183:Postoperative Complications / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000517:prevention & control*; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013923:Thromboembolism / Q000517:prevention & control; D013924:Thrombophlebitis / Q000517:prevention & control*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006886:Hydroxychloroquine; D005480:Flurbiprofen; D004176:Dipyridamole; D008012:Lidocaine; D002994:Clofibrate; D001241:Aspirin; D013442:Sulfinpyrazone
Valutazione critica dell'utilità dei farmaci inibitori della funzionalità piastrinica nella prevenzione della trombosi venosa profonda postoperatoria e nelle cardiopatie ischemiche.